Julphar plans to invest Dh300 million over next five years: CEO

Abu Dhabi: Abu Dhabi: Gulf Pharmaceutical Industries (Julphar) plans to invest Dh300 million over the next five years to expand its manufacturing base and localise advanced pharmaceutical technologies, CEO Basel Ziyadeh confirmed on Monday.

In statements made to the Emirates News Agency (WAM) on the sidelines of the first day of the “Make it in the Emirates 2025”, Ziyadeh said the investment will be made in collaboration with global partners and aims to support the UAE’s non-oil economy by increasing pharmaceutical exports.

He added that Julphar currently exports over 80% of its production to around 40 markets worldwide, underscoring the strength of its manufacturing infrastructure and local talent. Over the past three years, the company has already invested Dh100 million in upgrades and introduced more than 35 new products for both local and international markets.

Established over 45 years ago, Julphar is now one of the largest pharmaceutical manufacturers in the Arab region.